NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/18/2023
Back to search
Official data from USPTO
DICERNA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
59
Latest update
07/18/2023
Trademark type
Combined
Nice classes
42
Filing date
11/15/2019
Registration date
07/18/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/18/2023
Last transaction
07/18/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/14/2007
First use in commerce
11/14/2007
Drawing code
5
Owner type
03
Owner location
Lexington, MA, US
Examiner
OH, WON TEAK
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of "DICERNA" in stylized blue letters on a white background.
Holders and representatives
Holders
Dicerna Pharmaceuticals, Inc.
Dicerna Pharmaceuticals, Inc.
Representatives
Bridget H. Labutta Panitch Schwarze Belisario & Nadel LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of various diseasesrare diseasesgenetic disorderschronic liver diseasescardiovascular diseasescancersviral infections; research and development of pharmaceutical preparations for the treatment of liver-based disorders; research and development of oligonucleotide compounds for targeted gene silencing; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Publications
History of USPTO decisions and trademark events.
59 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/18/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/15/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/14/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/31/2023
IUAF
USE AMENDMENT FILED
05/26/2023
EISU
TEAS STATEMENT OF USE RECEIVED
05/26/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/07/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/07/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/07/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/03/2022
EX5G
SOU EXTENSION 5 GRANTED
12/02/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/02/2022
EXT5
SOU EXTENSION 5 FILED
11/22/2022
EEXT
SOU TEAS EXTENSION RECEIVED
11/22/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/27/2022
EX4G
SOU EXTENSION 4 GRANTED
05/25/2022
EXT4
SOU EXTENSION 4 FILED
05/25/2022
EEXT
SOU TEAS EXTENSION RECEIVED
05/25/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/25/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/25/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/25/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/02/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/02/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/02/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/13/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/13/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/13/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/05/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/05/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/05/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/05/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/05/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/19/2021
EX3G
SOU EXTENSION 3 GRANTED
11/17/2021
EXT3
SOU EXTENSION 3 FILED
11/17/2021
EEXT
SOU TEAS EXTENSION RECEIVED
11/17/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/27/2021
EX2G
SOU EXTENSION 2 GRANTED
05/25/2021
EXT2
SOU EXTENSION 2 FILED
05/25/2021
EEXT
SOU TEAS EXTENSION RECEIVED
05/25/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/25/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/25/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/25/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/01/2020
EX1G
SOU EXTENSION 1 GRANTED
11/27/2020
EXT1
SOU EXTENSION 1 FILED
11/27/2020
EEXT
SOU TEAS EXTENSION RECEIVED
11/27/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/26/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/31/2020
PUBO
PUBLISHED FOR OPPOSITION
03/31/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/11/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/25/2020
DOCK
ASSIGNED TO EXAMINER
02/20/2020
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
01/23/2020
ALIE
ASSIGNED TO LIE
01/22/2020
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
01/10/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/21/2019
NWAP
NEW APPLICATION ENTERED
11/19/2019
Continuous trademark protection
Get notified about every new filing that threatens DICERNA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.